BCL11B antisense RNA 1 (BCL11B-AS1)

BCL11B antisense RNA 1 (BCL11B-AS1) is a long non-coding RNA (lncRNA) transcribed from the region antisense to the BCL11B gene. It is classified as a non-coding RNA and does not encode a protein. Like other lncRNAs, BCL11B-AS1 is thought to be involved in the regulation of gene expression at the transcriptional and possibly post-transcriptional level. However, as of the latest data, there is very limited published functional characterization for BCL11B-AS1 specifically, in contrast to the well-studied protein-coding gene BCL11B. No data exist to support that BCL11B-AS1 is a direct therapeutic target, disease biomarker, or has drug interactions. Most data and disease relevance are available for the protein-coding gene BCL11B, not the antisense lncRNA. Note: - The name "BCL11B antisense RNA 1" is correct and refers to a lncRNA, not a receptor, enzyme, or typical therapeutic target. - Most PubMed and major gene database entries discuss BCL11B (the transcription factor), which is a protein-coding gene involved in immunity, development, and cancer, and is a known disease gene and possible therapeutic target[7][4][5][3][2][1]. - The lncRNA BCL11B-AS1 has very limited functional or clinical annotation, which is typical for many lncRNAs. If you are seeking structured data or target annotations for the protein-coding gene BCL11B (B-cell lymphoma/leukemia 11B), let me know, as information is much more extensive for the transcription factor than for its antisense RNA.

Other names

BCL11B-AS1BCL11B antisense non-coding RNA 1lnc-BCL11B-1